A 43-year systematic review and meta-analysis: Case-fatality and risk of death among adults with tuberculous meningitis in Africa

Journal of Neurology

Volumn 261, Issue 5, 2014, Pages 851-865

  Woldeamanuel, Yohannes W ^a,b   Girma, Belaineh ^c  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Monitoring and Evaluation Team USAID Management Sciences for Health Help Ethiopia Address Low TB (HEAL TB) Project   (Ethiopia)

Author keywords

Africa; Case fatality; Meningitis; Meta analysis; Systematic review; Tuberculous meningitis

Indexed keywords

TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT DISEASE; AFRICA; BACTERIAL STRAIN; CASE MANAGEMENT; CROWDING (AREA); DEATH; DISABILITY; FATALITY; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; NUTRITION; PATIENT REFERRAL; POVERTY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TUBERCULOUS MENINGITIS; ADULT; CASE CONTROL STUDY; CAUSE OF DEATH; EPIDEMIOLOGY; HIV INFECTIONS; TRENDS; TUBERCULOSIS, MENINGEAL;

ADULT; AFRICA; CASE-CONTROL STUDIES; CAUSE OF DEATH; HIV INFECTIONS; HUMANS; MORTALITY; RISK FACTORS; TUBERCULOSIS, MENINGEAL;

EID: 84901916736     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-7060-6     Document Type: Review

References (66)

1. WHO. Tuberculosis. Fact sheet # 104. 2012. Available from: http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 15 July 2013
2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163-2196
3. WHO. Health statistics and health information systems. Metrics: Disability-Adjusted Life Year (DALY) Quantifying the burden of disease from mortality and morbidity. Available from: http://www.who.int/healthinfo/global- burden-disease/metrics-daly/en/. Accessed 15 July 2013
4. WHO (2012) Global Tuberculosis Report. WHO/HTM/TB/2012.6
5. WHO (2012) Health statistics and health information systems. Global Burden of Disease (GBD). Available from: http://www.who.int/healthinfo/global- burden-disease/en/. Accessed 15 July 2013
6. WHO. Multidrug-resistant tuberculosis (MDR-TB). 2012 Update. 2012. Available from: http://www.who.int/tb/publications/MDRFactSheet2012.pdf. Accessed 15 July 2013
7. Davis LE, Rastogi KR, Lambert LC, Skipper BJ (1993) Tuberculous meningitis in the southwest United States: a community-based study. Neurology 43(9):1775-1778 (Pubitemid 23307953)
8. Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J (2000) Tuberculous meningitis. J Neurol Neurosurg Psychiatry 68(3):289-299 (Pubitemid 30248701)
9. Garg RK (1999) Tuberculosis of the central nervous system. Postgrad Med J 75(881):133-140
10. Waaler HT (2002) Tuberculosis and poverty. Int J Tuberc Lung Dis 6(9):745-746
11. WHO (2007) Global tuberculosis control: surveillance, planning, financing. WHO report 2007. WHO/HTM/TB/2007.376. Geneva, Switzerland
12. Phypers M, Harris T, Power C (2006) CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis 10(1):99-103 (Pubitemid 43266285)
13. Bishburg E, Sunderam G, Reichman LB, Kapila R (1986) Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 105(2): 210-213 (Pubitemid 16039296)
14. De Cock KM, Soro B, Coulibaly IM, Lucas SB (1992) Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 268(12):1581-1587
15. Curtis AB, Ridzon R, Vogel R, McDonough S, Hargreaves J, Ferry J et al(1999) Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 341(20):1491-1495 (Pubitemid 29526351)
16. Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ 342:d549
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557-560 (Pubitemid 37088507)
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748
19. Silber E, Sonnenberg P, Ho KC, Koornhof HJ, Eintracht S, Morris L et al (1999) Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci 162(1):20-26 (Pubitemid 29064113)
20. Madani N, Dendane T, Zekraoui A, Abidi K, Zeggwagh AA, Abouqal R (2009) Effects of corticosteroids on adults with tuberculous meningitis admitted to intensive care unit: a propensity score analysis. La Revue de medecine interne/fondee par la Societe nationale francaise de medecine interne 30(1):12-19
21. Patel VB, Padayatchi N, Bhigjee AI, Allen J, Bhagwan B, Moodley AA et al (2004) Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa. Clin Infect Dis 38(6):851-856 (Pubitemid 38387234)
22. Bhagwan S, Naidoo K (2011) Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis. AIDS Res Treat 2011:180352
23. Raviglione MC, Uplekar MW (2006) WHO's new stop TB strategy. Lancet 367(9514):952-955
24. Obermeyer Z, Abbott-Klafter J, Murray CJ (2008) Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS ONE 3(3):e1721
25. Marx GE, Chan ED (2011) Tuberculous meningitis: diagnosis and treatment overview. Tuberc Res Treat 2011:798764
26. Girgis N, Sippel J, Kilpatrick M, Sanborn W, Mikhail I, Cross E et al (1993) Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg 48(1):97-107 (Pubitemid 23072569)
27. Schoeman JF, Donald PR (2013) Tuberculous meningitis. Handb Clin Neurol 112:1135-1138
28. Donald PR (2010) Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinb) 90(5):279-292
29. WHO (2010) WHO Library Cataloguing-in-Publication Data: Treatment of tuberculosis: guidelines, 4th edn. WHO/HTM/TB/ 2009.420
30. Figaji AA, Sandler SI, Fieggen AG, Le Roux PD, Peter JC, Argent AC (2008) Continuous monitoring and intervention for cerebral ischemia in tuberculous meningitis. Pediatr Crit Care Med 9(4):e25-e30
31. Schoeman J, Mansvelt E, Springer P, van Rensburg AJ, Carlini S, Fourie E (2007) Coagulant and fibrinolytic status in tuberculous meningitis. Pediatr Infect Dis J 26(5):428-431 (Pubitemid 46789325)
32. Martinson NA, Karstaedt A, Venter WD, Omar T, King P, Mbengo T et al (2007) Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS 21(15):2043-2050 (Pubitemid 47462153)
33. Garg RK, Paliwal V, Malhotra HS (2011) Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis. Expert Rev Anti Infect Ther 9(9):719-729
34. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC et al (2004) Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 351(17):1741-1751
35. Coyle PK (1999) Glucocorticoids in central nervous system bacterial infection. Arch Neurol 56(7):796-801
36. Prasad K, Singh MB (2008) Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev (1): CD002244
37. Ogawa SK, Smith MA, Brennessel DJ, Lowy FD (1987) Tuberculous meningitis in an urban medical center. Medicine 66(4):317-326 (Pubitemid 17143603)
38. Humphries M (1992) The management of tuberculous meningitis. Thorax 47(8):577-581
39. Critchley JA, Young F, Orton L, Garner P (2013) Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 13(3): 223-237
40. Tandon V, Mahapatra AK (2011) Management of post-tubercular hydrocephalus. Childs Nerv Syst 27(10):1699-1707
41. Abrams JE (2013) "Spitting Is Dangerous, Indecent, and against the Law!" Legislating Health Behavior during the American Tuberculosis Crusade. J Hist Med Allied Sci 68(3):416-450. doi:10.1093/jhmas/jrr073
42. TB notifications since 1913 by site of disease. Statutory TB notification data for England & Wales by site of disease, for 1913 to 2011. Available from: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Tuberculosis/ TBUKSurveillanceData/TBUKSurveillanceViaNOIDs/TBNOIDs011913/. Accessed 15 Jul 2013
43. Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, Shears P et al (2002) Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg 96(3):242-249 (Pubitemid 34785056)
44. Christensen AS, Andersen AB, Thomsen VO, Andersen PH, Johansen IS (2011) Tuberculous meningitis in Denmark: a review of 50 cases. BMC Infect Dis 11:47
45. Afghani B, Lieberman JM (1994) Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 19(6):1092-1099 (Pubitemid 24380024)
46. Lolekha R, Chokephaibulkit K, Vanprapar N, Phongsamart W, Chearskul S (2003) Breakthrough neurological manifestation during appropriate antituberculous therapy of miliary tuberculosis. Southeast Asian J Trop Med Public Health 34(3):634-635 (Pubitemid 38068082)
47. Kelley CF, Armstrong WS (2009) Update on immune reconstitution inflammatory syndrome: progress and unanswered questions. Curr Infect Dis Rep 11(6):486-493
48. Singh A, Rahman H, Kumar V, Anila F (2013) An unusual case of paradoxical enlargement of lymph nodes during treatment of tuberculous lymphadenitis in immunocompetent patient and literature review. Am J Case Rep 14:201-204
49. Rabar D, Issartel B, Petiot P, Boibieux A, Chidiac C, Peyramond D (2005) Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment. Presse Med 34(1):32-34
50. Hejazi N, Hassler W (1997) Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Infection 25(4):233-239 (Pubitemid 27348158)
51. Sutlas PN, Unal A, Forta H, Senol S, Kirbas D (2003) Tuberculous meningitis in adults: review of 61 cases. Infection 31(6):387-391 (Pubitemid 38005368)
52. Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L et al (2013) Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in the camelia randomized. AIDS [Epub ahead of print]
53. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W et al (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8(8):516-523 (Pubitemid 352005824)
54. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10(4):251-261
55. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
56. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354(9193):1896-1900
57. Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A et al (2000) Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 14(10):1401-1407 (Pubitemid 30459513)
58. Burton NT, Forson A, Lurie MN, Kudzawu S, Kwarteng E, Kwara A (2011) Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana. Trans R Soc Trop Med Hyg 105(12): 675-682
59. Bergemann A, Karstaedt AS (1996) The spectrum of meningitis in a population with high prevalence of HIV disease. QJM 89(7):499-504 (Pubitemid 26245389)
60. Chapp-Jumbo EN (2006) Neurologic infections in a Nigerian university teaching hospital. Afr Health Sci 6(1):55-58
61. Berhe T, Melkamu Y, Amare A (2012) The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study. AIDS Res Ther 9:11
62. Ford H, Wright J (1994) Bacterial meningitis in Swaziland: an 18 month prospective study of its impact. J Epidemiol Community Health 48(3):276-280 (Pubitemid 24200498)
63. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH (1998) Tuberculous meningitis in South African urban adults. QJM 91(11):743-747 (Pubitemid 28508620)
64. Kilpatrick ME, Girgis NI, Farid Z, Sippel JE (1991) Epidemiology, prevalence and clinical diagnosis of meningitis at Abbassia Fever Hospital, Cairo, 1966-1989. Trans R Soc Trop Med Hyg 85(Suppl 1):4-5
65. Osuntokun BO, Adeuja AO, Familusi JB (1971) Tuberculous meningitis in Nigerians. A study of 194 patients. Trop Geogr Med 23(3):225-231
66. Soumaré M, Seydi M, Ndour C, Fall N, Dieng Y, Sow A et al (2005) Epidemiological, clinical, etiological features of neuromeningeal diseases at the Fann Hospital Infectious Diseases Clinic, Dakar (Senegal)] (Article in French). Med Mal Infect 35(7-8):383-389 (Pubitemid 41330957)